PULMOTECT, INC

Harnessing the Power of the Innate Immune System

PULMOTECT, INC was founded in 2015, is headquartered in Houston, United States, lists 1–10 employees, and has $32.0M in recorded funding across 6 rounds.

Headquarters
Houston, Texas
Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$32.0M
Last Round
$5.9M Series CSep 2024
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 4 investors for this company. The full record is or through the API.

About

Pulmotect is a clinical-stage biopharmaceutical company harnessing the innate immune system to prevent and treat respiratory infections. Its lead product, PUL-042, is an inhaled therapeutic that activates lung innate immunity, protecting against bacterial, fungal, and viral pathogens, with a focus on immunocompromised oncology patients.

Summary

PULMOTECT, INC is a Biotech company based in Houston, United States, founded in 2015. It lists 1–10 employees. It has raised $32.0M in total across 6 rounds, most recently a $5.9M Series C round in Sep 2024. Investors include Cancer Prevention and Research Institute of Texas, Fannin Partners LP (internal fund) and U.S. Department of Defense.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CSep 2024
$5.9M

Sign up to see all 6 events

Funding: Grant through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PULMOTECT, INC on Indexed.vc
<a href="https://indexed.vc/companies/pulmotect-inc"><img src="https://indexed.vc/api/badge/company/pulmotect-inc" alt="PULMOTECT, INC on Indexed.vc" width="260" height="76" /></a>